Utility of Two PANSS 5-Factor Models for Assessing Psychosocial Outcomes in Clinical Programs for Persons with Schizophrenia

Table 4

Random effects regression results.

Variable	𝐹	𝑃	AIC^a
RFS total—with PM covariates			1542.1
Treatment group	6.10	0.003
Occasion	2.58	0.02
Less than 8 prior admissions	6.73	0.01
PANSS PM negative score	23.34	<0.0001
PANSS PM positive score	23.42	<0.0001
RFS total—with VDG covariates			1538.8
Treatment group	6.40	0.002
Occasion	2.32	0.03
Less than 8 prior admissions	5.91	0.02
PANSS VDG negative score	6.72	0.01
PANSS VDG positive score	44.14	<0.0001
RFS total—with PM covariates			1484.0
Treatment group	5.40	0.006
Occasion	5.91	<0.0001
Less than 8 prior admissions	6.32	0.01
Medication compliance	5.31	0.02
PANSS PM activation score	8.75	0.003
PANSS PM autistic preoccupation	24.86	<0.0001
RFS total—with VDG covariates			1520.1
Treatment group	6.26	0.002
Occasion	4.01	0.0008
Less than 8 prior admissions	6.04	0.02
PANSS VDG disorganized score	36.78	<0.0001
PANSS VDG excited score	5.41	0.02
SAS-SMI total—with PM covariates			2431.1
Female	3.12	0.08
PANSS PM negative score	17.45	<0.0001
PANSS PM positive score	14.50	0.0002
SAS-SMI total—with VDG covariates			2399.7
Female	6.02	0.02
No schizoaffective diagnosis	4.84	0.03
Less than 8 prior inpatient admissions	4.46	0.04
PANSS VDG negative score	11.93	0.0006
PANSS VDG positive score	26.63	<0.0001
SAS-SMI total—with PM covariates			2430.1
Treatment group x occasion	1.89	0.04
PANSS PM activation score	7.05	0.008
PANSS PM autistic preoccupation score	7.07	0.008
SAS-SMI total—with VDG covariates			2416.1
Treatment group	2.33	0.01
PANSS VDG disorganized score	5.21	0.02
PANSS VDG excited score	10.69	0.001
CSQ total—with PM covariates			1531.8
Less than 8 prior inpatient admissions	8.92	0.004
PANSS PM negative score	12.18	0.0006
CSQ total—with VDG covariates			1523.4
Less than 8 prior inpatient admissions	7.13	0.009
PANSS VDG negative score	4.31	0.04
PANSS VDG positive score	14.07	0.0002
CSQ total—with PM covariates			1475.1
Less than 8 Prior inpatient admissions	8.35	0.005
Medication compliance	4.62	0.03
PANSS PM activation score	25.88	<0.0001
CSQ total—with VDG covariates			1474.6
Less than 8 prior inpatient admissions	8.72	0.004
Medication compliance	4.27	0.04
PANSS VDG excited score	27.76	<0.0001
Adherence—with PM covariates			3425.8
Occasion	5.22	<0.0001
Treatment group x occasion	3.34	0.0004
Less than 5 inpt days in 6 months prior to baseline	5.66	0.02
No anticholinergic use (Cogentin)	4.59	0.03
Adherence—with VDG covariates			3425.8
Occasion	5.22	<0.0001
Treatment group x occasion	3.34	0.0004
Less than 5 inpt days in 6 months prior to baseline	5.66	0.02
No anticholinergic use (cogentin)	4.59	0.03
Compliance—with PM covariates			702.1
Occasion	8.36	<0.0001
Treatment group x occasion	2.42	0.0007
No anticholinergic use (cogentin)	7.53	0.006
Compliance—with VDG covariates			702.1
Occasion	8.36	<0.0001
Treatment group x occasion	2.42	0.0007
No anticholinergic use (cogentin)	7.53	0.006

aAkaike information criteria.